Skip to main content

Resources

Practical information for you and your adult patients

Patient Materials

Breyanzi (lisocabtagene maraleucel) Patient Leaflet

A patient support booklet on what to expect from your treatment This booklet is intended for use only by patients who have been prescribed lisocabtagene maraleucel

2009-GB-2600045  |  April 2026

foot note heading

Prescribing Information can be accessed using the link on the top right of the page.

Adverse events should be reported. Reporting forms and information can be found at: UK - http://www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK).

Legal Notice    |    Privacy Policy     |    Cookie Preferences   

© 2026 Bristol-Myers Squibb Company. All rights reserved.

2009-GB-2600116  |  August 2026